(ATDN) Treatment Briefs: Zinc Finger Inhibitor for HIV

(ATDN) Treatment Briefs: Zinc Finger Inhibitor for HIV

Treatment Review No. 23 - December 1996

Another new class of anti-HIV drugs known as zinc finger inhibitors are entering clinical trials. These drugs block part of HIV known as zinc fingers. Zinc fingers are a part of HIV that help assemble new viruses as they are leaving an infected cell. When the zinc fingers are blocked, HIV makes copies of itself that don't work and can't infect new cells.

A zinc finger inhibitor called CI-1012 is being studied at the National Institutes of Health (NIH) in Bethesda, Maryland. To participate in this study you must have a T4 cell count between 200 and 500, and must not be on any anti-HIV treatment, or willing to stop anti-HIV treatment before joining the study. As with most studies at the NIH, they will pay airfare for every visit except the first. Call the Network for more information and referrals.

961201
ATR02315

Always watch for outdated information. This article first appeard in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 1996 - AIDS Treatment Data Network. If you want to copy, reproduce or excerpt this information, please give us a call at (800) 734-7104. This helps up to keep track of where and how this information is being used. You can also Email us at network@atdn.org http://206.179.124.69/network/index.html

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1996. AEGIS.